Biogen (BIIB) Other Non-Current Assets (2009 - 2026)

Biogen has reported Other Non-Current Assets for 18 years, with the latest figure at $831.8 million in Q2 2026.

• On a quarterly basis, Other Non-Current Assets rose 30.44% year-over-year to $831.8 million in Q2 2026; TTM through Jun 2026 was $831.8 million, a 30.44% increase from a year earlier, with the FY2025 full-year figure at $750.6 million, up 33.92% from the prior year.
• Other Non-Current Assets was $831.8 million for Q2 2026 at Biogen, up from $777.5 million in the prior quarter.
• The five-year high for Other Non-Current Assets was $1.8 billion in Q1 2022, with the low at $559.1 million in Q1 2025.
• Average Other Non-Current Assets over 5 years is $958.5 million, with a median of $752.6 million recorded in 2023.
• The sharpest annual moves came in 2023 and 2026: Other Non-Current Assets tumbled 53.21% in 2023, then soared 39.06% in 2026.
• Over 5 years, Other Non-Current Assets stood at $1.5 billion in 2022, then slumped by 51.28% to $745.0 million in 2023, then retreated by 24.77% to $560.5 million in 2024, then soared by 33.92% to $750.6 million in 2025, then grew by 10.82% to $831.8 million in 2026.
• The last three Other Non-Current Assets figures came in at $831.8 million (Q2 2026), $777.5 million (Q1 2026), and $750.6 million (Q4 2025), per Business Quant data.